tLNP CAR-T cell therapy (Taiwan Liposome)

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NametLNP CAR-T cell therapy (Taiwan Liposome)

Drug Alias NameN/A

ClassificationCell and gene therapy > Gene therapy > LNPCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT lymphocyte replacements

TargetsUpdating

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTaiwan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTaiwan Liposome Company Ltd

China Registration ClassN/A

Develop Information

Active CompaniesTaiwan Liposome Company Ltd

Inactive CompaniesN/A

Active IndicationsAutoimmune Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A